Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial (2021)
Attributed to:
An integrated epidemiological approach to understanding the relationship between lung health and multi-morbidity
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Journal Article/Review
Volume: 397
Parent Publication: LANCET
Issue: 10285
ISSN: 0140-6736